NeoGenomics (NEO) reported 164.5millioninrevenueforthequarterendedJune2024,representingayearover−yearincreaseof12164.5 million in revenue for the quarter ended June 2024, representing a yearover-year increase of 12%. EPS of 164.5millioninrevenueforthequarterendedJune2024,representingayearover−yearincreaseof120.03 for the same period compares to -$0.05 a year ago. ...